Major Depressive Disorder

Major Depressive Disorder (MDD) significantly impacts individuals with Alzheimer's Disease and dementia, exacerbating cognitive decline and reducing quality of life. The presence of MDD in these populations often complicates diagnosis and treatment due to overlapping symptoms such as apathy, sleep disturbances, and changes in appetite. Moreover, depression can accelerate cognitive decline and increase behavioral symptoms in dementia patients, posing challenges for caregivers and healthcare providers alike. Effective management involves a comprehensive approach including pharmacological interventions, psychotherapy, and caregiver support to address both MDD and the underlying neurodegenerative condition. Early detection and tailored interventions are crucial in improving outcomes and enhancing the overall well-being of individuals affected by Alzheimer's Disease and dementia with comorbid Major Depressive Disorder.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp